hematopathology testing PATIENTS.ANSWERS.RESULTS. OCTOBER 2018 www.aruplab.com Information in this brochure is current as of October 2018. All content is subject to change. Please contact ARUP Client Services at (800) 522-2787 with any questions or concerns. ARUP LABORATORIES As a nonprofit, academic institution of the University of Utah and its Department We believe in of Pathology, ARUP believes in collaborating, sharing knowledge, and contributing to laboratory science in ways that benefit our clients and their patients. collaborating, Our test menu is one of the broadest in the industry, encompassing more sharing than 3,000 tests, including highly specialized and esoteric assays. We offer comprehensive testing in the areas of genetics, molecular oncology, pediatrics, knowledge, and and pain management, among others. contributing ARUP’s clients include many of the nation’s university teaching hospitals to laboratory and children’s hospitals, as well as multihospital groups, major commercial laboratories, and group purchasing organizations. We do not compete with our science in ways clients for physician office business, choosing instead to support clients’ existing test menus by offering highly complex assays and accompanying consultative that provide support so clients can provide exceptional patient care in their local communities. the best value Offering analytics, consulting, and decision support services, ARUP provides clients with the utilization management tools necessary to prosper in this time of for the patient. value-based care. Our UM+ program helps clients control utilization, reduce costs, Together, and improve patient care. In addition, ARUP is a worldwide leader in innovative laboratory research and development, led by the efforts of the ARUP Institute for ARUP and ® Clinical and Experimental Pathology . its clients will ARUP’s reputation for quality is supported by our ability to meet or exceed the requirements of multiple regulatory and accrediting agencies and organizations. improve patient ARUP participates in the CAP laboratory accreditation program and has CLIA care today and certification through the Centers of Medicare and Medicaid Services. In December 2016, ARUP earned accreditation to the ISO 15189:2012 standard under CAP. in the future. patients. answers. results. A laboratory test is more than a number; it is a person, an answer, a diagnosis. HEMATOPATHOLOGY EXPERTISE The ARUP Hematopathology Laboratory and Hematopathology Division offer diagnostic consultative services and a comprehensive test menu for the evaluation of hematologic disorders. The division consists of nationally and internationally known medical professionals whose expertise spans many different subspecialties of hematopathology, including flow cytometry, immunohistochemistry, cytogenetics, coagulation, and molecular diagnostics. An integrated approach is utilized to provide clients with services ranging from test interpretation and selection to comprehensive histomorphologic diagnosis. For information regarding hematopathology consultation, please call (801) 581-5854. Archana Mishra Agarwal, MD Bo Hong, MD, FACMG Medical Director, Hematopathology and Special Genetics Medical Director, Cytogenetics and Genomic Microarray Dr. Agarwal is an associate professor of pathology at the University of Dr. Hong is an assistant professor of pathology at University of Utah Utah School of Medicine. She received her MD at Delhi University in India School of Medicine. She received her MD at Beijing Medical University and was a postdoctoral research scholar at the University of Iowa. She in Beijing, China, and completed a residency in internal medicine and served as a pathology resident, a hematopathology fellow, and a molecular hematology at People’s Hospital, Beijing Medical University, and a clinical genetics pathology fellow at the University of Utah School of Medicine. Dr. cytogenetics fellowship at the University of Utah. Her academic interests Agarwal is board certified in hematopathology, anatomic pathology, and include the clinical significance of cytogenetic findings in hematologic clinical pathology. She is also a member of several professional societies, malignancies, particularly in pediatric leukemia and treatment-related including the College of American Pathologists and the American Society leukemia. for Clinical Pathology. Dr. Agarwal’s research interests include red-cell enzymopathies, hemoglobinopathies, and molecular hematopathology. Erica Andersen, PhD, FACMG Kristin Hunt Karner, MD Medical Director, Cytogenetics and Genomic Microarray Medical Director, Hematopathology; Medical Director, Molecular Dr. Andersen is an assistant professor of pathology at the University Oncology; Director, Hematopathology Fellowship Program of Utah School of Medicine. She received her PhD in genetics from the Dr. Karner is an assistant professor of pathology at the University of University of Wisconsin–Madison and completed a clinical cytogenetics Utah School of Medicine. She received her MD from the University of fellowship at the University of Utah. She is board certified by the American Nebraska and completed her anatomic and clinical pathology residency Board of Medical Genetics and Genomics and Genomics and is a fellow of at the University of New Mexico. She also completed hematopathology the American College of Medical Genetics and Genomics. Dr. Andersen’s and molecular genetic pathology fellowships at the University of New interests include both constitutional and oncology cytogenetics. She is Mexico and is board certified by the American Board of Pathology in an active member of the Clinical Genome Resource (ClinGen) group’s anatomic and clinical pathology (AP/CP), as well as hematopathology and efforts to improve constitutional structural variant interpretation, and her oncology research molecular genetic pathology. Dr. Karner’s areas of focus include both lymphoid and myeloid projects include improving the diagnosis and monitoring for myelodysplastic syndromes and malignancies, and her current research interests include genetic aspects of myelodysplastic understanding the genetic etiology of rare histiocytic and dendritic cell neoplasms. syndrome and other myeloid malignancies. David W. Bahler, MD, PhD Allen N. Lamb, PhD, FACMG Medical Director, Hematopathology Section Chief, Cytogenetics and Genomic Microarray Dr. Bahler is an associate professor of pathology at the University of Utah Dr. Lamb is a professor of clinical pathology at the University of Utah School of Medicine. He is certified by the American Board of Pathology School of Medicine. He received his PhD from Wesleyan University in in clinical pathology, with an added qualification in hematology. Dr. molecular biology and biochemistry. He completed fellowships in clinical Bahler received his PhD in immunology and his MD from the University cytogenetics in the Department of Pediatrics at the University of North of Rochester. His research interests include the role of antigen receptor Carolina and in clinical molecular genetics at Harvard Medical School. Dr. stimulation in the development of lymphoid malignancies. Lamb is a founding fellow of the American College of Medical Genetics and Genomics and is certified by the American Board of Medical Genetics and Genomics in clinical cytogenetics. His primary areas of interest are in prenatal and postnatal chromosome diagnosis and the characterization of the phenotypic features (neurodevelopmental and physical development) associated with copy number changes. Julie Leana Cox, PhD, FACMG K. David Li, MD Medical Director, Cytogenetics Medical Director, Hematopathology Dr. Cox is board certified by the American Board of Medical Genetics and Genomics and Assistant Medical Director, Hematologic Flow Cytometry Genomics and is a diplomate in both clinical cytogenetics and clinical molecular genetics. Dr. Li is an assistant professor of pathology at the University of Utah Dr. Cox received master’s degrees in human genetics and administrative science from Johns School of Medicine. He received his MD from New York Medical College Hopkins University and a doctorate in human genetics from the University of Maryland at and completed a residency in anatomic and clinical pathology at the Baltimore. She completed a clinical cytogenetics and clinical molecular genetics fellowship University of California, San Diego. Dr. Li also completed a fellowship in at the University of Maryland, Division of Human Genetics. hematopathology at the University of Utah, and i s board certified by the American Board of Pathology in anatomic and clinical pathology, with subspecialty boards in hematology. Tracy I. George, MD Rodney R. Miles, MD, PhD Executive Director, Clinical Trials and PharmaDx Section Chief, Hematopathology Medical Director, Hematopathology Medical Director, Hematologic Flow Cytometry Dr. George is a professor of pathology at the University of Utah School Dr. Miles is an associate professor of pathology at the University of Utah of Medicine. She completed her MD and residency training in anatomic School of Medicine. He received his MD and a PhD in cell biology from the pathology and laboratory medicine at the University of California San University of Nebraska and is certified by the American Board of Pathology Francisco, with fellowships in hematopathology and surgical pathology in anatomic and clinical pathology, with subspecialty certification in at Stanford University. Dr. George is board certified in anatomic pathology, hematology. His